Prognostic Value of the Circumferential Resection Margin After Curative Surgery For Rectal Cancer: A Multicenter Propensity Score-Matched Analysis.
Autors de IIS La Fe
Autors aliens a IIS La Fe
- Galvez, Ana
- Biondo, Sebastiano
- Trenti, Loris
- Espin, Eloy
- Kraft, Miquel
- Farres, Ramon
- Codina-Cazador, Antonio
- Enriquez-Navascues, Jose M.
- Borda-Arrizabalaga, Nerea
- Kreisler, Esther
Grups d'Investigació
Abstract
BACKGROUND: In the past few years, positive circumferential resection margin has been found to be an indicator of advanced disease with high risk of distant recurrence rather than of local recurrence. OBJECTIVE: The objective was to analyze the prognostic impact of circumferential resection margin on local recurrence, distant recurrence, and survival rates in patients with rectal cancer. DESIGN: This was a multicenter, propensity score-matched analysis 2:1 comparing positive and negative circumferential resection margin. SETTINGS: The study was conducted at 5 high-volume centers in Spain. PATIENTS: Patients who underwent total mesorectal excision with a curative intent for middle-low rectal cancer between 2006 and 2014 were included. Clinical and histological characteristics were used for matching. MAIN OUTCOME MEASURES: The main outcomes were local recurrence, distant recurrence, overall survival, and disease-free survival. RESULTS: The unmatched initial cohort consisted of 1599 patients; 4.9% had a positive circumferential resection margin. After matching, 234 patients were included (156 with negative circumferential margin and 78 with positive circumferential margin). The median follow-up period was 52.5 months (22.0-69.5). Local recurrence was significantly higher in patients with positive circumferential margin (33.3% vs 11.5%; HR 3.2; 95% CI: 1.83-5.43; p < 0.001). Distant recurrence was similar in both groups (46.2% vs 42.3%; HR 1.09; 95% CI: 0.78-1.90; p = 0.651). There were no statistically significant differences in 5-year overall survival (48.6% vs 43.6%; HR 1.09; 95% CI: 0.92-1.78; p = 0.14). Disease-free survival was lower in patients with positive circumferential margin (36.1% vs 52.3%; HR 1.5; 95% CI: 1.05-2.06; p = 0.026). LIMITATIONS: This study was limited by its retrospective design. The different neoadjuvant treatment options were not been included in the propensity score. CONCLUSIONS: Positive circumferential resection margin is associated with higher local recurrence rate and worse disease-free survival in comparison with negative circumferential resection margin. However, positive circumferential resection margin was not a prognostic indicator of distant recurrence and overall survival. See Video Abstract at http://links.lww.com/DCR/B950.
Copyright © The ASCRS 2022.
Dades de la publicació
- ISSN/ISSNe:
- 0012-3706, 1530-0358
- Tipus:
- Article
- Pàgines:
- 887-897
- PubMed:
- 35348529
- Factor d'Impacte:
- 1,120 SCImago ℠
- Quartil:
- Q1 SCImago ℠
DISEASES OF THE COLON & RECTUM LIPPINCOTT WILLIAMS & WILKINS
Cites Rebudes en Web of Science: 2
Documents
- No hi ha documents
Filiacions
Projectes associats
MODELOS DE HÍGADO AISLADO PERFUNDIDO PARA EL RESCATE DE ÓRGANOS Y TRASLACIÓN DE LA TERAPIA GÉNICA EN EL TRASPLANTE: ESCENARIOS HUMANO "EX VIVO" Y PORCINO "IN VIVO"
Investigador Principal: RAFAEL LÓPEZ ANDÚJAR
2017_0270_CRC_LOPEZ . FUNDACION MUTUA MADRILEÑA . 2017
Ileostomía vistual combinada con endoscopia postoperatoria ebn cáncer de recto con escisión total mesorrectal. ¿podemos evitar estomas innecesarios? estudio prospectivo observacional multicénctrico.
Investigador Principal: BLAS FLOR LORENTE
PI17/00863 . INSTITUTO DE SALUD CARLOS III . 2018
"TIMing Evaluation of Stoma closure” Cierre precoz vs tardío del estoma derivativo tras cirugía de cáncer de recto.
Investigador Principal: MATTEO FRASSON
2018_0078_CRC_FRASSON . ASOCIACIÓN ESPAÑOLA DE COLOPROCTOLOGÍA (AECP) . 2018
Terápia génica no-viral con 1L 10 para el tratamiento de la enfermedad inflamatoria intestinal. Estudio preliminar con piezas de cólon humano ex vivo.
Investigador Principal: MATTEO FRASSON
PI18/01658 . INSTITUTO DE SALUD CARLOS III . 2019
Trocar multisensor para cirugía laparoscópica con presión de pneumoperitoneo individualizada
Investigador Principal: ÓSCAR DÍAZ CAMBRONERO
INNVAL10/18/056 . AGENCIA VALENCIANA DE LA INNOVACION (AVI) . 2018
INDIVIDUALIZED PERIOPERATIVE HEMODYNAMIC GOAL-DIRECTED THERAPY IN MAJOR ABDOMINAL SURGERY (IPEGASUS-TRIAL).
Investigador Principal: ÓSCAR DÍAZ CAMBRONERO
IPEGASUS . 2017
MU OPIOID RECEPTOR 1 (MOR-1) EXPRESSION IN COLORECTAL CANCER AND DISEASE-FREE SURVIVAL RELATIONSHIP (MOROCCO). FIVE-YEAR FOLLOW-UP.
Investigador Principal: ÓSCAR DÍAZ CAMBRONERO
ODC-MOR-2018-01
ESTUDIO PROSPECTIVO, ALEATORIZADO, DOBLE-CIEGO, INTERNACIONAL Y MULTICÉNTRICO SOBRE LA SEGURIDAD Y LA EFICACIA DE LA SOLUCIÓN 6% HIDROXIETIL ALMIDÓN (HYDROXYETHYL STARCH) (HES) COMPARADA CON UNA SOLUCIÓN ELECTROLÍTICA EN PACIENTES SOMETIDOS A CIRUGÍA ABDOMINAL: ESTUDIO PHOENICS.
Investigador Principal: ÓSCAR DÍAZ CAMBRONERO
HC-G-H-1504 (PHOENICS) . 2018
CHAIMELEON. ACCELERATING THE LAB TO MARKET TRANSITION OF AI TOOLS FOR CANCER MANAGEMENT.
Investigador Principal: LUIS MARTÍ BONMATÍ
952172 . COMISION EUROPEA . 2020
PRESIÓN INDIVIDUALIZADA DE INSUFLACIÓN DEL PNEUMOPERITONEO EN CIRUGÍA LAPAROSCÓPICA COLORECTAL FRENTE A TERAPIA ESTÁNDAR.
Investigador Principal: ÓSCAR DÍAZ CAMBRONERO
IPPCOLLAPSE-II . 2016
ESTUDIO ALEATORIZADO MULTICÉNTRICO EN FASE III DE RADIOTERAPIA DE CORTA DURACIÓN SEGUIDA DE QUIMIOTERAPIA PREOPERATORIA DE LARGA DURACIÓN Y CIRUGÍA EN EL CÁNCER RECTAL PRIMARIO DE ALTO RIESGO EN COMPARACIÓN CON QUIMIORRADIOTERAPIA CONVENCIONAL Y CIRUGÍA Y OPTIMA QUIMIOTERAPIA ADYUVANTE.
Investigador Principal: JORGE APARICIO URTASUN
RAPIDO